Latin America Immunotherapy Drugs Market, by drug type (monoclonal antibodies, interferons, interleukins, vaccines and checkpoint inhibitors), by application (Blood Cancer, Cervical Cancer, Breast Cancer, Glioblastoma, Lung Cancer, Gastric Cancer, Prostate Cancer and Melanoma) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Latin America Immunotherapy Drugs Market, by drug type (monoclonal antibodies, interferons, interleukins, vaccines and checkpoint inhibitors), by application (Blood Cancer, Cervical Cancer, Breast Cancer, Glioblastoma, Lung Cancer, Gastric Cancer, Prostate Cancer and Melanoma) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1160 | Pages: 127 | November 2016 | Region: Latin America


Latin America Immunotherapy Drugs Market is estimated to be USD 3.42 billion and is projected to reach USD 5.36 billion by 2021 with a significant CAGR of 9.4%. The need for immunotherapy drugs is on the rise with the increase in number of autoimmune diseases and cancer incidences. This coupled with the lesser side effects of Immunotherapy drugs is expected to result in a positive outlook of the market in the review period.

Immunotherapy is a type of treatment for cancer which enhances the immune system to fight against cancer. Immunotherapies either stimulates the activity done by a particular component of the immune system or counteract the immune system produced by the cancer cells suppressing the immune responses.

Rising incidences of cancer and other autoimmune diseases has led to innovations in the development of drugs with the help of technological advancements. The others factors responsible for the growth of the market includes emergence of biosimilars, higher efficacy than the common drugs with lower side effects and reduction in the overall time of developing and testing of new drugs. However, the market is restrained by the higher cost related to the treatment and lower accessibility.

Latin America Immunotherapy Drugs are classified based on the type of drugs and by application. Based on the type of drugs, the market is categorised into checkpoint inhibitors, monoclonal antibodies, vaccines, interleukins and interferons. On the basis of application the market is categorised into Cervical Cancer, Lung Cancer, Blood Cancer, Glioblastoma, Breast Cancer, Prostate Cancer, Gastric Cancer and Melanoma. On the basis of geography, Latin America market is segmented into Mexico, Brazil and Argentina.

The major companies leading in the Immunotherapy drugs industry include Novartis, Seattle Genetics, Eli Lilly, GlaxoSmithKline PLC, AstraZeneca, Amgen, Bristol Myers Squibb, Roche, Merck and Merck.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Drug Type                             

                                5.1.1 Monoclonal Antibodies     

                                5.1.2 Interferons             

                                5.1.3 Interleukins            

                                5.1.4 Vaccines  

                                5.1.5 Checkpoint Inhibitors         

                5.2 By Application                           

                                5.2.1 Blood Cancer         

                                5.2.2 Cervical Cancer     

                                5.2.3 Breast Cancer        

                                5.2.4 Glioblastoma         

                                5.2.5 Lung Cancer           

                                5.2.6 Gastric Cancer       

                                5.2.7 Prostate Cancer    

                                5.2.8 Melanoma              

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Argentina                    

                6.5 Rest of Latin America                             

7. Pipeline Product Analysis                                        

                7.1 Overview                                    

                7.2 Pipeline Development Landscape                                     

                7.3 Molecular Targets in the Pipeline                                     

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                 

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.               

8. Strategic Analysis                                       

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9. Market Leaders' Analysis                                        

                9.1 Eli Lilly                           

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Merck                           

                9.3 Roche                           

                9.4 Amgen                         

                9.5 Novartis                       

                9.6 Celgene                       

                9.7 AstraZeneca               

                9.8 Bristol Myers Squibb                              

                9.9 GlaxoSmithKline PLC                              

                9.10 Seattle Genetics                    

10. Competitive Landscape                                         

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11. Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America Immunotherapy Drugs Market By Region, From 2016-2021 (USD Billion)
  2. Latin America Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  3. Latin America Monoclonal Antibodies Market By Region, From 2016-2021 (USD Billion)
  4. Latin America Interferons Market By Region, From 2016-2021 (USD Billion)
  5. Latin America Interleukins Market By Region, From 2016-2021 (USD Billion)
  6. Latin America Vaccines Market By Region, From 2016-2021 (USD Billion)
  7. Latin America Checkpoint Inhibitors Market By Region, From 2016-2021 (USD Billion)
  8. Latin America Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  9. Latin America Blood Cancer Market By Region, From 2016-2021 (USD Billion)
  10. Latin America Cervical Cancer Market By Region, From 2016-2021 (USD Billion)
  11. Latin America Breast Cancer Market By Region, From 2016-2021 (USD Billion)
  12. Latin America Glioblastoma Market By Region, From 2016-2021 (USD Billion)
  13. Latin America Lung Cancer Market By Region, From 2016-2021 (USD Billion)
  14. Latin America Gastric Cancer Market By Region, From 2016-2021 (USD Billion)
  15. Latin America Prostate Cancer Market By Region, From 2016-2021 (USD Billion)
  16. Latin America Melanoma Market By Region, From 2016-2021 (USD Billion)
  17. Brazil Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  18. Brazil Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  19. Argentina Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  20. Argentina Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  21. Mexico Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  22. Mexico Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
Middle East And Africa Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & ...
Latin America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Asia Pacific Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnol...
Europe Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Co...
North America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies...
Middle East And Africa Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics),...
Latin America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Asia Pacific Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User ...
Europe Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospi...
North America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospital, Cl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.